Form 8-K - Current report:
SEC Accession No. 0001641172-25-015665
Filing Date
2025-06-20
Accepted
2025-06-20 06:01:59
Documents
13
Period of Report
2025-06-18
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 56223
  Complete submission text file 0001641172-25-015665.txt   273161

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE hrow-20250618.xsd EX-101.SCH 4221
3 XBRL DEFINITION FILE hrow-20250618_def.xml EX-101.DEF 27000
4 XBRL LABEL FILE hrow-20250618_lab.xml EX-101.LAB 38544
5 XBRL PRESENTATION FILE hrow-20250618_pre.xml EX-101.PRE 25620
15 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 6647
Mailing Address 1A BURTON HILLS BLVD SUITE 200 NASHVILLE TN
Business Address 1A BURTON HILLS BLVD SUITE 200 NASHVILLE TN 615.733.4731
HARROW, INC. (Filer) CIK: 0001360214 (see all company filings)

EIN.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35814 | Film No.: 251058922
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)